Lupin trades with traction on the BSE

20 Aug 2014 Evaluate

Lupin is currently trading at Rs 1243.15, up by 26.70 points or 2.19% from its previous closing of Rs 1216.45 on the BSE.

The scrip opened at Rs 1216.45 and has touched a high and low of Rs. 1246.60 and Rs 1214.35 respectively. So far 40408 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs. 1221.00 on 19-Aug-2014 and a 52 week low of Rs. 742.30 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs. 1221.00 and Rs. 1158.00 respectively. The current market cap of the company is Rs. 55710.26 crore.

The promoters holding in the company stood at 46.73% while Institutions and Non-Institutions held 42.72% and 10.55% respectively.

Lupin has entered into a strategic distribution agreement with LG Life Sciences (South Korea) to launch Insulin Glargine, a novel insulin analogue under the brand name Basugine. According to the agreement, Lupin would be responsible for marketing and sales of Basugine in India.

The overall diabetes market size within the Indian Pharmaceutical Market (IPM) stood at Rs 6,032 crore growing at 18%, as per IMS MAT April 2014. The total insulin analogue market size is valued at Rs 585 crore with 3 year CAGR of 24%. The total Glargine molecule market is Rs 218.5 crore with 3 year CAGR of 23%.

Lupin ranks second in the conventional insulin market and grew more than the market at 10.82% in April 2014, as per IMSD MAT, while the market grew at 8%. Lupin is amongst the fastest growing players in the OAD (Oral Anti-Diabetes Drugs) market and also in the insulin segment.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

 

Lupin Share Price

2137.15 -27.90 (-1.29%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×